'Evaluatie van biomarkers in VTE studie met capillair bloed monster; de EVA-II studie'
Recruiting
- Conditions
- Venous thrombosis, pullmonary embolism
- Registration Number
- NL-OMON26166
- Lead Sponsor
- Jeroen Bosch Hospital
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 350
Inclusion Criteria
Patients with suspected Venous TromboEmbolism, in whom the GP orders a
D-dimer test.
- Life expectancy more than 3 months.
Exclusion Criteria
- Age below 18 year; anticoagulant treatment (vitamin K, NOAC, low molecular-
weight heparin) for other causes than VTE: pregnancy or a life expectancy
less than three months. Unwilling to practicipate in this study
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective of this study is an analytic validation of D-dimer tests with capillary whole blood of six different, recently introduced POC laboratory devices compared with a central routine lab D-dimer assay. <br><br>
- Secondary Outcome Measures
Name Time Method Secondary objective are i) a clinical validation according to VTE diagnosis, as a Gold Standard is lacking for D-dimer measurement. ii) to evaluate the added diagnostic value of inflammatory biomarkers and coagulation markers